ValuationViz

ARQT fund manager activity

Arcutis Biotherapeutics, Inc · Nasdaq. Reported by 2 tracked fund managers in their 13F filings, Q4 2025 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Ron Baron - Baron CapitalAdded1,253,120$32,856,8060.05%Aug 14, 2026
Joel Greenblatt - Gotham Asset ManagementNew19,032$499,0190.00%Aug 14, 2026

Q1 2026

ManagerActivitySharesValue% of portfolioFiled
Ron Baron - Baron CapitalAdded1,072,189$25,260,7730.08%May 15, 2026

Older quarters